A Agilent Technologies

FY2025 10-K
Filed: Dec 22, 2025
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Agilent Technologies (A) filed its fiscal year 2025 10-K annual report with the SEC on Dec 22, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Provider of scientific instruments and analytical solutions for laboratories and research
  • No new products, services, or business segments introduced or emphasized in this year's filing
+3 more insights

Management Discussion & Analysis

  • Revenue and profitability figures not disclosed in provided MD&A text
  • No segment performance data provided in excerpt
+2 more insights

Risk Factors

  • Regulatory risk from Inflation Reduction Act 2022, 1% nondeductible excise tax on stock repurchases payable, $3 million recorded in fiscal 2025
  • Geopolitical risk from U.S. tariff changes in H2 2025 increasing cost of revenue; mitigation expected in fiscal 2026 through supply chain and pricing actions
+3 more insights

Financial Summary
XBRL

Revenue

$6.9B

Net Income

$1.3B

Operating Margin

21.3%

Net Margin

18.8%

ROE

19.3%

Total Assets

$12.7B

EPS (Diluted)

$4.57

Operating Cash Flow

$1.6B

Source: XBRL data from Agilent Technologies FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Agilent Technologies

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available